Moreover, SUMOylation contributes to pathogenesis of T-cell lymphomas expressing the oncogenic NPM-anaplastic lymphoma kinase (NPM-ALK) fusion protein via SUMO-dependent post-translational stabilization of NPM-ALK [192]. This evidence concerns the gene ALK and T-cell non-Hodgkin lymphoma.